US OptionsDetailed Quotes

KOD250117C500

Watchlist

2.03
0.000.00%

15min DelayClose Dec 27 16:00 ET

0.00High0.00Low

Kodiak Sciences Stock Discussion

Jsmooth420365

Dec 4 04:15

$Kodiak Sciences (KOD.US)$ riding 9 nicely 👌 looking for possible swing entry on pullback

George Soros II

Oct 18 10:07

$Kodiak Sciences (KOD.US)$

Meltyy

May 16 01:14

🔔 Baker Bros. Q1 ‘24* Holdings Released... 🐳

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...

Jaguar8

May 13 19:31

$Kodiak Sciences (KOD.US)$
NEWS
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy

Jaguar8

May 2 15:39

$Kodiak Sciences (KOD.US)$
NEWS
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform

JuliaBiswas

Feb 5 04:12

Who is the winner today, after the poditive data announced on 03 Feb
$EyePoint Pharmaceuticals (EYPT.US)$
$Adverum Biotechnologies (ADVM.US)$
$Regenxbio (RGNX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Kodiak Sciences (KOD.US)$

JuliaBiswas

Feb 4 22:11

$Kodiak Sciences (KOD.US)$ announced first time results of KSI-501 ABC Phase 1 study. The data outlined safety and biocativity of KSI-501, along with high binding affinity and bioactivity against VEGF and IL-6.

Moomoo AI

Jan 26 05:03

While Kodiak Sciences' cash runway is reassuring, its cash burn relative to its market cap is concerning. The company's high expenditure relative to its market value suggests an elevated risk of funding distress, making the stock a risky investment.

Here's Why We're Watching Kodiak Sciences' (NASDAQ:KOD) Cash Burn Situation

Shukri Saham Global

Nov 6, 2023 17:45

Market Snapshot 7th Nov, 2023

- 📈 Dow Jones extends its winning streak to six sessions, the longest since late July.
- 🇺🇸 U.S. stocks had their best week of 2023.
- 💹 Dow Jones gained 0.1%, the S&P 500 rose 0.2%, and the Nasdaq Composite was up 0.3%.
- 📅 Monday marked the Nasdaq's seventh consecutive day of gains, matching a win streak last seen in January.
- 📊 Last week saw significant gains, with the Dow Jones up 5.1%, the S&P 500 up 5.9%, and the Nasdaq Composite up 6.6%.
- 📉 Bond yields tempo...

Alvinnnnnnngenius

Sep 7, 2023 05:05

$Kodiak Sciences (KOD.US)$ announces one-year topline data for its ABC Platform based investigational therapy tarcocimab tedromer from the pivotal BEACON study in patients with macular edema due to retinal vein occlusion (RVO)

No comment yet